Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Ohio Board of Nursing Proposes Rule Changes for Nurses

Client Alert

On Monday, January 12, 2026, the Ohio Board of Nursing released a package of proposed changes to the Ohio Administrative Code.  While most of the rules had no proposed changes or merely proofreading changes, there was one rule change that will be of significant interest to our LPN, RN, and APRN clients.

Ohio Board of Nursing Proposed Rule Changes - a medical professional's arm holding a stethescope.

OAC 4723-14-01 sets forth definitions related to continuing education (CE) requirements.  There are two proposed changes that Ohio nurses should be watching. 

First, under Section (E), the definition for “Category A” credits would be adjusted to allow for CE credits that may be offered by an approved organization that is not headquartered in Ohio.  This may expand a nurse’s CE opportunities. 

Second, under Section (U), the “Reporting Period” definition would be adjusted.  LPNs, RNs, and APRNs would now have a reporting period of July 1 – June 30 in odd numbered years.  (The current reporting period is November through October.)  If this change is adopted, nurses will want to be aware, so that they don’t miss any deadlines. 

As a reminder, proposed changes to the Ohio Administrative Code trigger a public hearing.  As such, If you or your organization wish to submit comments or give testimony on any of the proposed rules discussed herein, please note that there is a hearing scheduled for February 13, 2026.

If you would like assistance with laws governing Ohio’s nurses or in preparing comments on potential regulatory changes, please contact BMD Health Law Group member, Jeana Singleton at jmsingleton@bmdllc.com or 330-253-2001. 

 


Compounding GLP-1 Drugs - Recent Updates

Recent guidance from the Ohio Board of Pharmacy (“BOP”) indicates that providers should generally use the FDA approved GLP-1 drug, rather than a non-FDA approved compounded version of the medication. Importantly, if a GLP-1 drug is commercially available, it cannot be copied through compounding. Currently, compounded copies of Tirzepatide and Semaglutide are not permitted.

Top Compliance Risks for Ohio Med-Spas in 2025

The Ohio Board of Pharmacy has increased inspections of med-spas holding Terminal Distributor of Dangerous Drugs (TDDD) licenses, with many facing enforcement actions in 2025. Common issues include purchasing from unlicensed distributors, improper drug storage, inadequate recordkeeping, and insufficient prescriber oversight. Understanding these risks and maintaining compliance can help protect your practice from penalties and license suspension.

Pre and Postnuptial Agreements | Necessary, Maybe, What Happened to Forever?

Both Florida and Ohio now allow clients to enter into a prenuptial or postnuptial agreement prior to marriage or after marriage (Ohio previously did not allow postnuptial agreements). Both documents have statutory guidelines that must be followed in terms of execution and financial disclosure.

DHS Ends All Employment Authorization Auto-Extensions

Effective October 30, 2025, DHS ends all automatic work authorization renewals. The 540-day extension applies only to renewals filed before this date, and there is no grace period for expired EADs filed on or after October 30. Employers must audit EADs, train staff, ensure I-9 compliance, and plan for work authorization gaps. Penalties for noncompliance can be severe.

CMS’s Rural Health Funding Announcement

CMS has announced a $50 billion Rural Health Transformation (RHT) Program to improve healthcare access, quality, and outcomes in rural communities. All states are eligible to apply for funding by November 5, 2025. Half of the funds will be distributed equally, with the remainder based on state-specific factors. The program supports evidence-based initiatives, workforce recruitment, and access to treatment services, with awards assessed annually